Costi S

Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; Oxford Health Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK; Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

4 papers · 1 preprint

ArticleKetamine

Ketamine attenuates habenula activity in response to aversive outcomes during Pavlovian learning.

Pulcu E, Costi S, Artiach-Hortelano P +8

Europe PMC2026
PreprintKetamine

Ketamine attenuates habenula activity in response to aversive outcomes during Pavlovian learning

Pulcu E, Costi S, Artiach-Hortelano P +8

Europe PMC2026
ArticleKetamine

The cognitive neuroscience of ketamine in major depression.

Costi S, Wigg C, Pulcu E +2

Europe PMC2025
ArticleKetamine

Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial.

Feder A, Brown O, Rutter SB +15

Europe PMC2025
ArticleKetamine

Ketamine for Major Depressive Disorder.

Costi S

Europe PMC2024